Stockreport

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

Telesis Bio, Inc.  (TBIO) 
PDF SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling resear [Read more]